RGC EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
-4.7% vs SMA 50 · -1.9% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $2.9B $2.8B–$2.9B | — | $8.83 | — | ±5% | High5 |
FY2025 | $3.7B $3.6B–$3.7B | ▲ +27.0% | $13.43 | ▲ +52.1% | ±2% | High6 |
FY2026(current) | $4.7B $4.4B–$5.1B | ▲ +28.1% | $19.12 | ▲ +42.4% | ±12% | High7 |
Dividend per payment — last 8 periods
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff…

evercore (nyse: evr) is a premier global independent investment banking advisory firm. we are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure. evercore also assists clients in raising public and private capital and delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. founded in 1995, the firm is headquartered in new york and maintains offices and affiliate offices in major financial centers in north america, europe, south america, the middle east and asia. for more information, please visit www.evercore.com.investment banking - corporate advisory - restructuring advisory - strategic shareh
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
EVR◀ | $316.69 | -1.43% | $12.5B | 16.5 | +2949.3% | 1525.5% | 1500 |
| $397.67 | +0.41% | $2.1T | 28.7 | +3296.8% | 4510.0% | 1500 | |
| $91.95 | +0.10% | $316.0B | 14.1 | +318.8% | 1510.7% | 1500 | |
| $131.46 | -0.32% | $305.1B | 22.6 | +586.3% | 1305.9% | 1500 | |
| $184.74 | -1.40% | $286.4B | 27.2 | +862.9% | 1745.9% | 1500 | |
| $146.57 | -0.87% | $279.7B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $88.98 | -1.86% | $251.9B | 14.4 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | -0.77% | — | 20.6 | +1145.8% | 1975.8% | 1500 |